Rondaxe Pharmaceutical Company

There are always obstacles, regardless of how smart a firm may be. In the Ghostbusters films, the tagline "Who you going to call?" was coined; nevertheless, Ghostbusters is unlikely to respond to your call. Since 2001, Rondaxe has provided consulting services to our customers, and we have seen a number of extremely consistent reasons why a consulting firm can provide substantial value.

Find a Consulting Business That Meets Your Needs

According to an ancient saying, people employ those whom they know and trust. This proverb applies whether you are recruiting individuals or a corporation that will substantially influence your organization.

Keep in mind that "Pharmaceutical Consulting" is a vast area. Others may specialize in clinical research, while others may specialize in contract acquisition. Before you even begin your search for a consulting partner, you should define your primary need. We advise you to ask yourselves a few fundamental questions:

What seems to be the issue – what are we attempting to resolve?

What is our greatest worry about the situation at hand?

What seems to be our greatest challenge?

What is preventing us from tackling this matter?

Once we've answered the questions at hand, we'll discuss your vision of what you need, and therefore, the qualities a possible partner must possess. This straightforward method can help you restrict your search and zero in on a partner with the proper skills to drive your success.

Past and Future Prospects

This may sound obvious, yet we often see organizations entering and exiting the consulting industry all the time. Therefore, you must choose a partner like Rondaxe that not only has the necessary expertise but will also be there tomorrow. Learn their experience, the sorts of goods they've launched, and the challenges they've encountered. This can give crucial information on their capacity to manage and respond to your unique demands. In addition, since we live in a small world, the length of time a firm has been in operation and its reputation are always significant.

Search for an Adaptable Business

The pharmaceutical industry is full of surprises and rapid changes, so you need an adaptable firm that can deal with problems as they emerge. Competent consultants should be able to think creatively and adapt as new information is obtained. In addition, the industry is evolving fast in terms of technology, digitalization, patient care paradigms and other factors. Is your consultant aware of these shifting actions, plus be able to give direction in a changeable market environment? A partner who can adapt to your company's needs will make the cooperation process effective.

Consider Their Communication Skills

The communication skills of a potential consulting partner are a crucial (but sometimes ignored) aspect of identifying a competent one. When scheduling early meetings and interviews with the company, pay close attention to their communication skills:

Are they able to express their competencies with precision?

Are they available to take your calls, even at odd hours?

Do they answer promptly and professionally to emails?

Finding responsive and highly communicative partners makes it much simpler to communicate on day-to-day project management issues. Existing and rising pharmaceutical companies need the optimal combination of knowledge, adaptability and customer service. By evaluating the above features, you can find a company with the appropriate skills for your project and business objectives. Investing a bit of extra effort up front can go a long way toward ensuring that you locate the finest consulting partner available. 

“Process validation” is predicated on recognizing that a single test of a drug's final formulation is insufficient to ensure public safety and high-quality patient care. As stated by the FDA, this observance highlights that the manufacturing and commercialization validation processes are crucial to the product's quality assurance.

Here we provide a definition and explanation of process validation from a functional standpoint. In addition, a summary of the 3 steps of process validation and their justifications are offered.

The goal is to help readers comprehend how their businesses can effectively handle the problems of FDA-compliant large-scale commercialization while preserving medication quality, efficacy and safety.

What Is Process Validation?

The FDA defines process validation as "the gathering and assessment of data, from the stage of process design to commercial production, that produces scientific proof that a process is capable of consistently providing quality output”.

The lifespan idea is a key principle of this FDA guideline. The lifetime approach is not only concerned with the initial medication development procedures, but also with the creation of commercial manufacturing and normal commercial production up to the product's demise.

Validation of Pharmaceutical Process Principal Components

Incorporating quality assurance measures into each phase of the drug manufacturing process is a second fundamental premise of process validation.

The 3 stages of validation of a process are:

Process Design – The commercial production procedure is defined

Process Qualification – The design is assessed to see whether the processes fulfill repeatability requirements

Continual Process Verification – Assurances that all processes continue to be under control

Before production and commercialization, producers should ensure the goods they want to commercialize can achieve the required quality standards, and that the specified manufacturing techniques can accommodate safety and effectiveness requirements.

Manufacturers should also be aware of the possible Active Pharmaceutical Ingredient (API) and drug product changes which can emerge during commercialization and scale-up. They must make every effort to comprehend the fluctuation's origin, magnitude and effect.

In addition, it is vital to have a strategy to manage differences and adhere to FDA regulations.

The primary purpose is thus to design, develop, and manage the drug manufacturing process in order to generate medicines that fulfill the following essential characteristics:

Identity

Quality

Strength

Potency

Purity

Regulatory Requirements and Obligations

Current Good Manufacturing Practices (cGMP) play a significant role in pharmaceutical process validation operations. Several of these are legally binding requirements. 

The FDA has concluded that a completed drug product is adulterated (i.e., degraded by adding another material) when requirements cannot consistently and reliably achieve a predetermined quality throughout production, processing, packaging and storage.

In addition to sampling and testing, additional control methods are required to confirm the production processes which may produce a variation. All samples must be representative of the batch being analyzed, according to statistical principles of confidence and fulfill the batch's parameters.

Section 211.180(e) requires that information about product quality and manufacturing procedures is routinely reviewed and modified. Consequently, continuous reviews to gather input about good manufacturing procedures is essential to cGMP compliance.

Lastly, cGMP stipulates that drug-manufacturing facilities' size, structure, and placement must be adequate to fulfill regulatory requirements. All equipment must be tested and calibrated following industry standards.

There are requirements mandating documentation of methods for manufacture and process control to ensure goods possess the claimed identity, strength, quality, purity and potency.

General FDA Recommendations and Considerations

The FDA offers several suggestions for methods which industry leaders can follow to maintain standardization in data collecting and other information (and to increase accessibility so that advantages can be realized later in the product's lifespan):

The FDA advises a team-based approach to process validation, in which specialists from a number of disciplines cooperate on the most suitable methods and practices.

There is a significant opportunity for various researchers to investigate, uncover, and observe facts regarding medicinal products and procedures. As long as all research guidelines are adhered to, they are strongly recommended.

All qualities (quality, product, component) and parameters (process, operational, equipment) must have controls proportional to their process and product risk.